SCHEMBL7066729

SCHEMBL7066729

Cc1ccc(S(=O)(=O)ON(N=Cc2cc([N+](=O)[O-])ccc2Cl)C(=N)N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
LMNA P02545 4/20 0.53
TDP1 Q9NUW8 1/20 0.53
MAPT P10636 10/20 0.45
GAA P10253 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HTT P42858 2/20 0.44
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
AMY1A P0DUB6 1/20 0.39
CCNT1 O60563 1/20 0.37
FLT3 P36888 1/20 0.37
PIK3CA P42336 1/20 0.37
CDK9 P50750 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062256 0.89 ALDH1A1 (0.41) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7062491 0.89 ALDH1A1 (0.44) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7062930 0.87 ALDH1A1 (0.39) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7065577 0.85 ALDH1A1 (0.37) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7066010 0.85 GRIN2D (0.41) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7066015 0.83 KMT2A (0.38) ALDH1A1LMNATDP1MAPTNPSR1
SCHEMBL915169 0.83 ALDH1A1 (0.53) ALDH1A1LMNATDP1MAPTPOLB
SCHEMBL7060993 0.83 MAPT (0.42) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7065013 0.82 ALDH1A1 (0.39) ALDH1A1LMNATDP1MAPTGAA
SCHEMBL7064848 0.82 ALDH1A1 (0.39) ALDH1A1LMNATDP1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed